United States · FDA National Drug Code directory
Dapsone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70771-1538_ae448df2-611f-4d56-911f-11d01983726f
- Product NDC
- 70771-1538
- Form
- GEL
- Composition / generic term
- Dapsone
- Labeler
- Zydus Lifesciences Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240510
- Source listing expiry
- 20261231
Source-listed ingredients
- DAPSONE — 75 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, PUMP in 1 CARTON (70771-1538-2) / 30 g in 1 BOTTLE, PUMP · 70771-1538-2
- 1 BOTTLE, PUMP in 1 CARTON (70771-1538-3) / 60 g in 1 BOTTLE, PUMP · 70771-1538-3
- 1 BOTTLE, PUMP in 1 CARTON (70771-1538-8) / 90 g in 1 BOTTLE, PUMP · 70771-1538-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →